<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0345">
 <label>27</label>
 <element-citation publication-type="journal" id="sbref0345">
  <person-group person-group-type="author">
   <name>
    <surname>Van Assche</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Vermeire</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ballet</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Gabriels</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Noman</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>dâ€™Haens</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: Prospective randomised SWITCH trial</article-title>
  <source>Gut.</source>
  <volume>61</volume>
  <year>2012</year>
  <fpage>229</fpage>
  <lpage>234</lpage>
  <pub-id pub-id-type="doi">10.1136/gutjnl-2011-300755</pub-id>
  <pub-id pub-id-type="pmid">21948942</pub-id>
 </element-citation>
</ref>
